abi-h2158
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 13, 2018 (NCT03714152)
Timeline
Indications
Studied for
Mechanism of action
- Hepatitis B virusINHIBITOR
Hepatitis B virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04398134 | Phase 2 | May 28, 2020 | Assembly Biosciences |
| NCT04142762 | Phase 1 | Nov 4, 2019 | Assembly Biosciences |
| NCT04083716 | Phase 1 | Sep 6, 2019 | Assembly Biosciences |
| NCT03714152 | Phase 1 | Nov 13, 2018 | Assembly Biosciences |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Assembly Biosciences | For profit | 4 | 4 | 2 | 2018 |
1 organizations
Page 1 / 1